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ATIENUATED ANF-MEDIATED NEPHROGENOUS CYCLIC GMP 
GENEMTION IN ADVANCED CONGESTIVE HEART FAILURE 
Pe neb B, Msrgulies, Linda J. McKinley, John A. Schirger, and John 
C. Lumen Jr Mayo Clinic and Foundation, Rochester, MN 
Previous’st&es have demonstrated that the biologic actions of auial 
nauiuretic factor (ANF) are media@ via increases 61 its inlracellular 
second messenger cyclic GMP (CGMP). Recent reports suggest that 
exuacellular cGMP may be a useful biologic maxicer for the action of ANF 
in uivo under pathophysiologic conditions. Therefore, the present studies 
qed the hypothesis that the avid sodium nzsention and renal ANF 
resistance characteristic of chronic CHF are associated with attenuated 
nephrogenous cGMP responses fo ANF. We assessed the natriuretic and 
nephrogenous cGMP responses to endogenous and exogenous ANF 
during the evolution of congestive heart failure (CHF) produced by six 
days of rapid cardiac pac~c~;iogs (n=6). 
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* denotes ~0.05 vs. Baseline. Abbreviations: UNaV-absolute 
sodium ex’cretion, FEcGMP-fractional excretion of cGMP. 
In early CHF, increased sodium excretion and nephrogenous cGMP 
production were observed in association with increases in plasma ANF. 
Exogenous ANF administration (10 @kg iv) prior 10 CHF also produced 
highly significant and parallel increases in sodium excretion and 
nephrogenous cGMP production. In more advanced CHF, we observed 
avid sodium retention in association with reversal of earlier increases in 
nephrogenous cGMP despite funher increases in circulating plasma ANF. 
Natriuretic and nephrogenous cGMP responses to exogenous ANF were 
likewise attenuated after 6 days of CHF. These studies suggest: 
1) nephrogenous cGMP production is a usefui biologic marker for the 
renal natiuretic action of ANI? 2) endogenous ANF contributes 10 the 
maintenance of sodium excretion in early CHF via increases in 
nephrogenous cGMP production; and 3) the avid sodium retention and 
renal Al* resistance III advanced CHF are, in part, linked 10 attenuated 
renal cGMP responses 10 endogenous and exogenous ANF. 
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SUSTAINED AUGMENTATION OF PARASYMPATHETIC TONE WITH 
CHRONIC ANGIOTENSIN CONVERTING ENZYME INHIBITION IN 
CONGESTIVE HEART FAILURE. 
Phi ID F. Blnktgy, Enrico Nun&&t, Garrle J. Haas, Robert J. Cody. The Ohio 
Bta:e Untverslty, cdumbus, Ohio. 
We have previously reported that signlficent restoration of parasympathetic 
(para) tone accompanies first dose anglotensln converting enzyme (ACE) 
Inhlbl!ion In congestive heart failure (CHF) as evidenced by an increase in 
para mediated high frequency heart rate variability. We tested the 
hypothesis that long term ACE inhlbltion produces sustained augmentation 
of pare tone In a randomized placebo controlled trial of the Investigational 
ACE Inhibitor Zofenopril. In all subjects, the resting electrocardiogram was 
recorded for the analysls of frequency composltlon of heart reBle variability at 
bsseline and after 3 months of therapy. The power denstty spectrum of 
heart rate variabilii was generated from these recordings and the area 
under the curve bounded by specific frequency bands was used lo 
determlne their contribution 10 overall variability. In the ACE Inhibitor group 
(10 patients) the pare mediated hlgh frequency (s.1 hz) area was found to 
significantly (p= .03) increese from 0.5x10-3* 1.0x10-3 to 2.0x1 O-3 + 1 xl o-3 
beats/mln2 (bpm2). There was no significant change in the sympathetically 
Influenced low frequency (e.lhz) area. In contrast, in the placebo control 
group (5 patients) there was no change in the high frequency area which 
WBS measured as 0.5x10-3* 1.0 x10-3 bpm2 at baseline and 0.4~10.3+0.3x 
lo-3 at the end of 3 months. These placebo controlled data Indicate that 
long term ACE inhlbitlon In congesttve heart failure results in a sustained 
augmentation of parasympsthetlc tone thus restoring the autonomic profile 
toWard normal. These autonomic effects of ACE inhibitors may contribute 
lo their well known hemodynamlc and clinical benefit In chronic congestive 
heetl fellure. 
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Abrupt vessel closure within 24 hours of PTCA is a major 
problem with an associated high risk of KI., CA% and 
death. Among the causes of abrupt closure are believed 
to be elastic recoil and dissection or flaps suddenly 
occluding the blood supply. Percutaneous Transluminal 
Coronary Rotational Ablation (PTCRA) with the Rotablator 
(R) (Heart Technology, Inc.) uses a high speed rotating 
diamond studded tip to remove atheromatous material 
while sparing normal healthy tissue, 
the vessel wall. We evaluated the co 
flap/dissections elastic recoil and subsequent abrupt 
closure associated with PTCRA. 
In the treatment of 366 lesions (315 patients), there 
were 261315 (8.2%) cases of angiographic evidence of a 
flap or a dissection. All but one case either required 
no treatment or were resolved with a balloon. One case 
(l/315, 0.3%) required CABG. 
A subset (120 lesions) had 24 hour post-procedure 
angiography. Results were : 
Pre-R Stenosis 84.3 
Post-R Stenosis 29.0% 
% Stenosis at 24 hr F.U. 23.3% 
e 20% loss of initial gain 3.3% 
There were zero cases of abrupt closure post-cath lab. 
Conclusion : The Rotablator produced a highly 
predictable result with minimal loss of initial gain, a 
low level of serious flap/dissection and no abrupt 
closures post-cath lab. 
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PER-S CDRQrURY EXCIMER LP&Sm AWIOPLASTY: 
QUANTITATIVE ANGIOGRRPHIC ANALYSIS 
CORREWITION PJFIWEEN P0ST-LASER RESIwfRL S 
SIX ImTR FoLIxkJ-lrP SlmGSIS 
Sabino R. lbtre, 
Douglas Israel, J 
Timothy A. Sanborn, Samin Sharm, 
Ambrose. Wt.Sinai 
&mm, c Cohen, John A. 
Center, York, New York 
Initial clinical trials demonstrate the safety and 
efficacy of percutaneous coronary excimer laser 
angioplasty(ELA), however, the optilpal post-laser 
residual stenosis that will result in a better 
long-term angiographic outcome is not known. Therefore, 
quantitative angiography 
initially and aEZ?or symptcm rela 
47 patients that underwent ELA. Linear rearession 
analysis demonstrated a significant correlation”&ween 
the post-laser residual stenosis(PLRS) and the 
folluw-up stenosis(m0.3, pCO.001). No correlation was 
found between either the initial or post-m stenosis 
and the follo+up stenosis(r-0.08, p=NS). Subgroup 
analysis demonstrated that only those EZA procedures in 
which the PLRS was <30% resulted in a sianificantlv 
improved long-term angiographic outcome bean&D) : *PC. o’s 
PLRSn 
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&Se quantitative angmgraphic analysis of acute an& 
long-term ELA restits - dkonstrat~ a significant 
positive correlation between the extent of plaque 
ablation and the long-term angiographic outccune. 
Specifically, a PLBS of <30% resulted in a 
significantly lower follaw-up stenosis(29% vs 64%, 
p<O.OS). These findings underscore the critical 
relationship between the extent of laser plaque 
ablation and long-term angiographic outcane. 
